Clinical Trial Update: Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. [Phase 3]

View source ↗

Summary

Phase 3 trial update on primary and booster vaccination with a pneumococcal vaccine in diverse HIV exposure/infection statuses among infants; results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Streptococcal

Drugs mentioned

• GlaxoSmithKline pneumococcal vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 3 | Status: COMPLETED | Results posted: 2012-07-06